U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07079020) titled 'Efgartigimod for Consolidation Therapy in gMG' on June 29.
Brief Summary: The goal of this observational study is to evaluate the efficacy and safety of consolidation therapy with corticosteroids and/or immunosuppressants combined with efgartigimod in patients with generalized myasthenia gravis after the acute exacerbation.
Study Start Date: July 30
Study Type: OBSERVATIONAL
Condition:
Myasthenia Gravis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Da, Yuwei, M.D.
Disclaimer: Curated by HT Syndication....